Krill-Burger M, Dempster JM, Borah AA, et al. Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal. Genome biology. 2023;24(1):192. doi:10.1186/s13059-023-03020-w.
Doherty T, Yao Z, Khleifat AAL, et al. Artificial intelligence for dementia drug discovery and trials optimization. Alzheimer’s & dementia : the journal of the Alzheimer’s Association. 2023. doi:10.1002/alz.13428.
Trastulla L, Savino A, Beltrao P, et al. Highlights from the 1st European cancer dependency map symposium and workshop. FEBS letters. 2023. doi:10.1002/1873-3468.14699.
Way G, Natoli T, Adeboye A, et al. Morphology and gene expression profiling provide complementary information for mapping cell state. Cell systems. 2022;13(11):911-923.e9. doi:10.1016/j.cels.2022.10.001.
Fanning S, Haque A, Imberdis T, et al. Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment. Mol Cell. 2019;73(5):1001-1014.e8. doi:10.1016/j.molcel.2018.11.028.
Rees MG, Seashore-Ludlow B, Clemons PA. Computational Analyses Connect Small-Molecule Sensitivity to Cellular Features Using Large Panels of Cancer Cell Lines. Methods Mol Biol. 2019;1888:233-254. doi:10.1007/978-1-4939-8891-4_14.
Leifer BS, Doyle SK, Richters A, Evans HL, Koehler AN. An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives. Methods Enzymol. 2018;610:191-218. doi:10.1016/bs.mie.2018.09.019.